South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugs

The shortage highlights a widening gulf in the standard of care for people with diabetes, most of whom live in low-income countries.The shortage highlights a widening gulf in the standard of care for people with diabetes, most of whom live in low-income countries.Read MoreDiabetes, Drugs (Pharmaceuticals), Income Inequality, Insulin, Medicine and Health, Hypodermic Needles and Syringes, Government Contracts and Procurement, Semaglutide (Drug), Ozempic (Drug), Novo Nordisk A/S, South Africa, Wegovy, your-feed-science, your-feed-healthcareNYT > Health